Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$105,000.00

Therapeutics in coronary thrombosis

EF 2022-23

Résumé
The most dangerous type of heart attack, ST-elevation myocardial infarction (STEMI), happens when a blood clot completely blocks an artery in the heart, called a coronary artery. Despite re-opening the coronary artery with a metallic mesh tube-shaped scaffold called a stent, approximately 1 in 10 patients will die within a year due to extensive heart damage. Blood clots traveling downstream and blocking blood flow in smaller arteries may contribute as oxygen cannot reach the heart muscle cells, leading to irreversible damage despite the main artery being open. New catheters have been developed to go inside the coronary arteries and provide continuous vacuum suctioning to remove blood clots before opening stents, thus decreasing the risk of blood clots migrating. This new technology, mechanical thrombectomy, may reduce the damage caused by heart attacks. Using different study types, we will 1) investigate how well mechanical thrombectomy removes blood clots by studying x-ray films of arteries (coronary angiograms) and 2) investigate what effect mechanical thrombectomy has on mortality, recurrent heart attacks, and heart failure in patients with an initial heart attack. I will lead the studies conducted during this Ph.D. with the Acute Coronary Syndromes and Interventional Cardiology research group at the Population Health Research Institute. The results of these studies will influence cardiology practice around the world and improve the care of patients with heart attacks.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
474300
Name
d'Entremont Marc-André
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Therapeutics in coronary thrombosis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Acute Coronary Syndromes; Colchicine; Heparin; Percutaneous Coronary Intervention; Randomized Clinical Trial; Spironolactone; St-Elevation Myocardial Infarction; Thrombectomy
Abstract
The most dangerous type of heart attack, ST-elevation myocardial infarction (STEMI), happens when a blood clot completely blocks an artery in the heart, called a coronary artery. Despite re-opening the coronary artery with a metallic mesh tube-shaped scaffold called a stent, approximately 1 in 10 patients will die within a year due to extensive heart damage. Blood clots traveling downstream and blocking blood flow in smaller arteries may contribute as oxygen cannot reach the heart muscle cells, leading to irreversible damage despite the main artery being open. New catheters have been developed to go inside the coronary arteries and provide continuous vacuum suctioning to remove blood clots before opening stents, thus decreasing the risk of blood clots migrating. This new technology, mechanical thrombectomy, may reduce the damage caused by heart attacks. Using different study types, we will 1) investigate how well mechanical thrombectomy removes blood clots by studying x-ray films of arteries (coronary angiograms) and 2) investigate what effect mechanical thrombectomy has on mortality, recurrent heart attacks, and heart failure in patients with an initial heart attack. I will lead the studies conducted during this Ph.D. with the Acute Coronary Syndromes and Interventional Cardiology research group at the Population Health Research Institute. The results of these studies will influence cardiology practice around the world and improve the care of patients with heart attacks.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
d'Entremont, Marc-André
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~